Nitric oxide, atrial natriuretic peptide, and cyclic GMP inhibit the growth-promoting effects of norepinephrine in cardiac myocytes and fibroblasts
- PMID: 9466976
- PMCID: PMC508629
- DOI: 10.1172/JCI119883
Nitric oxide, atrial natriuretic peptide, and cyclic GMP inhibit the growth-promoting effects of norepinephrine in cardiac myocytes and fibroblasts
Abstract
This study tested the hypothesis that nitric oxide (NO) and atrial natriuretic peptide (ANP) can attenuate the effects of adrenergic agonists on the growth of cardiac myocytes and fibroblasts. In ventricular cells cultured from neonatal rat heart, ANP and the NO donor S-nitroso-N-acetyl-D,L-penicillamine (SNAP) caused concentration-dependent decreases in the norepinephrine (NE)-stimulated incorporation of [3H]leucine in myocytes and [3H]thymidine in fibroblasts. In myocytes, the NO synthase inhibitor NG-monomethyl-L-arginine potentiated NE-stimulated [3H]leucine incorporation. In both cell types, ANP and SNAP increased intracellular cGMP levels, and their growth-suppressing effects were mimicked by the cGMP analogue 8-bromo-cGMP. Furthermore, in myocytes, 8-bromo-cGMP attenuated the alpha1-adrenergic receptor-stimulated increases in c-fos. Likewise, ANP and 8-bromo-cGMP attenuated the alpha1-adrenergic receptor- stimulated increase in prepro-ANP mRNA and the alpha1-adrenergic receptor-stimulated decrease in sarcoplasmic reticulum calcium ATPase mRNA. The L-type Ca2+ channel blockers verapamil and nifedipine inhibited NE-stimulated incorporation of [3H]leucine in myocytes and [3H]thymidine in fibroblasts, and these effects were not additive with those of ANP, SNAP, or 8-bromo-cGMP. In myocytes, the Ca2+ channel agonist BAY K8644 caused an increase in [3H]leucine incorporation which was inhibited by ANP. These findings indicate that NO and ANP can attenuate the effects of NE on the growth of cardiac myocytes and fibroblasts, most likely by a cGMP-mediated inhibition of NE-stimulated Ca2+ influx.
Similar articles
-
Inhibition of beta- but not alpha 1-mediated adrenergic responses in isolated hearts and cardiomyocytes by nitric oxide and 8-bromo cyclic GMP.Cardiovasc Res. 1996 Sep;32(3):622-9. Cardiovasc Res. 1996. PMID: 8881523
-
Natriuretic peptides modulate nitric oxide synthesis in cytokine-stimulated cardiac myocytes.J Mol Cell Cardiol. 1997 Sep;29(9):2375-82. doi: 10.1006/jmcc.1997.0472. J Mol Cell Cardiol. 1997. PMID: 9299361
-
eNOS, nNOS, cGMP and protein kinase G mediate the inhibitory effect of pancreastatin, a chromogranin A-derived peptide, on growth and proliferation of hepatoma cells.Regul Pept. 2005 Feb 15;125(1-3):41-6. doi: 10.1016/j.regpep.2004.07.031. Regul Pept. 2005. PMID: 15582712
-
[Regulation of cardiac calcium current by cGMP/NO route].C R Seances Soc Biol Fil. 1996;190(2-3):181-206. C R Seances Soc Biol Fil. 1996. PMID: 8869231 Review. French.
-
Cell death, survival and proliferation in Tetrahymena thermophila. Effects of insulin, sodium nitroprusside, 8-Bromo cyclic GMP, NG-methyl-L-arginine and methylene blue.Cell Biol Int. 1996 Oct;20(10):653-66. doi: 10.1006/cbir.1996.0087. Cell Biol Int. 1996. PMID: 8969458 Review.
Cited by
-
Cardiovascular Effects of Stimulators of Soluble Guanylate Cyclase Administration: A Meta-analysis of Randomized Controlled Trials.Curr Atheroscler Rep. 2024 May;26(5):177-187. doi: 10.1007/s11883-024-01197-4. Epub 2024 Apr 2. Curr Atheroscler Rep. 2024. PMID: 38564140 Review.
-
The role of cardiac microenvironment in cardiovascular diseases: implications for therapy.Hum Cell. 2024 May;37(3):607-624. doi: 10.1007/s13577-024-01052-3. Epub 2024 Mar 18. Hum Cell. 2024. PMID: 38498133 Review.
-
Comparing the signaling and transcriptome profiling landscapes of human iPSC-derived and primary rat neonatal cardiomyocytes.Sci Rep. 2023 Jul 28;13(1):12248. doi: 10.1038/s41598-023-39525-4. Sci Rep. 2023. PMID: 37507481 Free PMC article.
-
The Microenvironment of the Pathogenesis of Cardiac Hypertrophy.Cells. 2023 Jul 4;12(13):1780. doi: 10.3390/cells12131780. Cells. 2023. PMID: 37443814 Free PMC article. Review.
-
The NO-cGMP-PKG Axis in HFpEF: From Pathological Mechanisms to Potential Therapies.Aging Dis. 2023 Feb 1;14(1):46-62. doi: 10.14336/AD.2022.0523. eCollection 2023 Feb 1. Aging Dis. 2023. PMID: 36818566 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous